2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Monday, June 7, 2021

4:30pm-4:35pm: Use of a Novel Bead-based Assay to Measure the Impact of Imlifidase on ABO IgG Antibodies

A. Halpin¹, B. Motyka², T. Ellis², J. Pearcey², T. L. Lowary³, A. Runström⁴, L. Winstedt⁴, R. Bockermann⁴, S. Järnum⁴, A. Robertson⁴, L. J. West⁵

Biomarkers, Immune Assessment and Clinical Outcomes - III • Virtual

4:35pm-4:40pm: A Mechanistic Evaluation to Guide the Optimal Immunosuppression Adjustment Strategy in Transplant Patients with COVID-19

V. Hall, V. Ferreira, D. Kumar, A. Humar

Late-Breaking: COVID-19 • Virtual

4:35pm-4:40pm: Cytomegalovirus (CMV) D+/R- Serostatus is Independently Associated with Mortality and Graft Loss After Liver Transplantation (LTx)

P. Vutien, J. Perkins, S. Biggins, J. Reyes, A. Limaye

Infectious Disease Poutpouri • Virtual

4:35pm-4:40pm: High Levels of Donor-Derived Cell-Free DNA Predict EGFR Decline After Kidney Transplantation

T. Alhamad¹, V. Bowers², E. Stites³, S. Anand⁴, J. S. Bromberg⁵, H. Murad¹, G. Gupta⁶, I. Moinuddin⁶, L. Bu⁷, S. Ghosh⁸, J. Zeng⁸, A. Pai⁹

Biomarkers, Immune Assessment and Clinical Outcomes - III • Virtual

4:35pm-4:40pm: Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts

V. Gorbacheva, R. Fan, W. Baldwin, R. Fairchild, A. Valujskikh

B cell/Antibody and Histocompatibility • Virtual

4:35pm-4:40pm: Relationship of Functional Frailty and Radiographic Sarcopenia to Outcomes After Liver Transplant

S. L. Olson, P. Polineni, W. Schwartz, O. Siddiqui, L. Zhao, D. Ganger, D. P. Ladner

Liver Recipient Selection • Virtual

4:35pm-4:40pm: The Effect of the Different Donor-Derived HLA T-Cell Epitope Targets on the Development of T Cell-Mediated Rejection After Kidney Transplantation

A. Senev, E. Van Loon, M. Emonds, M. Naesens

Kidney: Acute Cellular Rejection • Virtual

4:35pm-4:40pm: The Initial Impact of Covid-19 on Reported Graft Failure Rates and Potential Confounding of Srtr Psrs

A. Wey¹, J. Miller¹, D. Musgrove¹, Y. Ahn¹, M. Valapour², N. Salkowski¹, M. Skeans¹, A. Massie³, R. Hirose⁴, D. Segev³, A. Israni¹, J. Snyder¹, B. Kasiske¹

Quality Assurance and Regulatory Issues • Virtual

4:40pm-4:45pm: Acoustofluidic Device to Remove Donor Specific Antibody in a Sensitized Animal Model

J. Kwun¹, E. David², Y. Gu³, Z. Ma³, M. Kuchibhatla⁴, G. Arepally⁵, T. J. Huang³, E. T. Chambers²

B cell/Antibody and Histocompatibility • Virtual

4:40pm-4:45pm: Assessment of Donor-Derived Cell-Free DNA Performance Characteristics Across the Spectrum of TCMR and ABMR After Kidney Transplant

L. Bu¹, S. Anand², A. Pai³, J. S. Bromberg⁴, T. Alhamad⁵, V. Bowers⁶, I. Moinuddin⁷, S. Ghosh⁸, W. Tian⁸, E. Stites⁹, G. Gupta⁷

Biomarkers, Immune Assessment and Clinical Outcomes - III • Virtual